Story
Glycation and anti-glycation
Glucose attaches to proteins without enzymes and ends up as irreversible AGEs, building up most in long-lived proteins such as collagen. Forming fewer AGEs comes down to blood sugar and cooking temperature, not anti-glycation pills.
Last updated
Overview and key questions
In short: Glucose in the blood attaches itself to proteins without the help of any enzyme.
Educational content, not medical advice. See a clinician about your own case.
The kind without an enzyme: Glucose in the blood attaches itself to proteins without the help of any enzyme, and this is called glycation.
Sugar sticks to hemoglobin: Glucose attaches to the valine at the start of hemoglobin's β chain, first loosely, then slowly locking into a stable form that barely comes off for the cell's life.
Story path
Chapter 1
Sugar sticks to protein on its own
Glycation happens in three steps. The sugar first links to an amino group on the protein's lysine or arginine, forming a Schiff base; the Schiff base slowly rearranges into a more stable Amadori product. Both of these steps can still go backwards. After that, the products are oxidized, broken apart, or bridged to a neighboring protein, and they become advanced glycation end products, AGEs for short, which cannot go back.
How much forms depends on two things: how concentrated the sugar is, and how long the protein has been soaking in it. So it happens in everyone's body; AGEs form and build up both in normal aging and in diabetes.
Take an office worker who has a milk tea every afternoon. The reaction in that body is the same one as in anyone else's; the main difference is how high blood sugar rises and how long it stays high.
Mechanism · Kitchen browning and typical AGEs
Within proteins, AGEs sit mainly on the side chains of lysine and arginine. Studies usually measure three representative compounds: carboxymethyllysine (CML), carboxyethyllysine (CEL) and pentosidine.
Evidence · A large family with no single test
The field has a long-standing problem as well: there is no universally established method of detection and no common unit of measurement. AGE values reported by different studies often cannot be compared directly.
So when you read an AGE measurement, first ask which compound was measured and by what method.
Chapter 2
HbA1c is a glycation readout
Glucose attaches to the amino acid at the very start of hemoglobin's β chain, a valine, first forming an aldimine that comes undone easily, then slowly rearranging into a far more stable ketoamine that barely comes off for the rest of the red cell's life. The red cell does not remove the sugar; it can only wait until the cell reaches the end of its life and is replaced as a whole.
Take someone who starts cutting back on sugary drinks after a checkup: at the follow-up test, the weeks since the change carry the most weight in the reading.
A caution: HbA1c measures how high the sugar in the blood has been, not how many AGEs have already built up in skin and blood vessels.
Mechanism · Where the sugar sits on hemoglobin
Other factors can also push the reading off. Anemia, recent blood loss or transfusion, some hemoglobin variants, and the second and third trimesters of pregnancy all interfere with it, and in those cases diagnosis switches to blood glucose measures.
Numbers · A weighted average over ~100 days
From this, the authors worked out a weighting curve for each marker: blood sugar in the few days before the blood draw carries the most weight, and the weight shrinks further back. HbA1c looks back roughly 100 days, glycated albumin about 40 days, and fructosamine about 30 days.
A caution: there were only 9 people and no control group, and the weighting curves were calculated by assuming blood sugar dropped in a single step and fitting a theoretical model. HbA1c is a weighted average that leans toward recent weeks, not a simple average of three months of blood sugar.
Numbers · Turning HbA1c into average glucose
A caution: the people enrolled had stable blood sugar and no red blood cell disorders, children and pregnant women were excluded, and people of Asian and African descent were underrepresented; the authors state that the results apply directly only to this population. For most people with diabetes, HbA1c can be translated into an average blood sugar.
Chapter 3
Long-lived proteins get cross-linked
AGEs form bridges between neighboring collagen fibers and pin the fibers together, so the tissue becomes stiffer and less flexible. Collagen that sugar has modified is also harder for the enzymes that break down collagen to take apart.
AGEs also bind a receptor on the cell surface called RAGE. RAGE can catch several kinds of molecules: besides AGEs, there are inflammatory molecules such as calgranulins and HMGB1, and so it links glycation to inflammation and to the complications of diabetes. A caution: the evidence for this pathway comes mostly from animal and cell experiments, and no RAGE blocker has yet been shown to work in the clinic.
Take a forty-year-old: some of the collagen in their skin has already been in use for more than ten years, and the AGEs on it have built up bit by bit over those years.
Evidence · The longer a protein lives, the more it collects
The reason is turnover. By the study's estimates, cartilage collagen has a half-life of about 117 years and skin collagen about 15 years. Once turnover was corrected for, the two kinds of collagen accumulated AGEs at exactly the same rate. The authors concluded that how slowly a protein is renewed is a major factor in how many AGEs it collects.
A caution: this was a cross-sectional measurement of human tissue that looked only at cartilage and skin; the half-lives are model estimates; and turnover is one major factor, not the only one. The longer a protein stays in use and the more slowly it is replaced, the more glycation it accumulates.
The lens and the artery wall. Beyond skin and cartilage, two other places come up often. One is the lens of the eye, whose crystallin proteins are almost never replaced. In one test-tube experiment, lens proteins incubated with sugars gave yellow, fluorescent pigments and cross-links resembling those reported in aging and cataractous human lenses. The researchers proposed that exceptionally long-lived proteins such as lens crystallins and skin collagen are the ones most likely to be slowly damaged by sugar. This was a test-tube experiment, so it shows a possibility.
The other is the artery wall. One study stained human tissues with an antibody that recognizes one AGE, carboxymethyl-lysine: in skin, heart, kidney and above all arteries it increased with age, and faster in diabetes; the elastic membrane of the artery wall stained heavily, and atherosclerotic plaques held a lot of it. This is where it sits in tissue sections; it shows where AGEs accumulate, not on its own that they cause arteries to stiffen.
Evidence · Skin after five years of tight control
These collagen measures were linked to complications in the retina, kidneys and nerves, and most of the links stayed significant after adjusting for .
A caution: in the group with longer-standing diabetes, the differences in CML and acid-soluble collagen did not reach significance; and the links to complications were comparisons at a single point in time. Glycation in tissue changes with blood-sugar control, and it carries information that HbA1c does not.
Evidence · Skin collagen and complications ten years on
This offers one explanation for metabolic memory: the effect of how high blood sugar ran in earlier years may stay in the tissue in the form of glycated collagen.
A caution: this is an observational study; it shows only that the collagen measures are linked to later complications, not that bringing down glycation in the skin would prevent them. Glycation in skin collagen may record a longer history of blood sugar than HbA1c does, but whether it is a cause, this study cannot answer.
Chapter 4
AGEs on the plate
Once eaten, most of the AGEs attached to large proteins cannot be absorbed; only the small-molecule ones and those attached to short peptides can pass from the gut into the blood. AGEs that reach the blood have to be cleared by the kidneys.
In human trials, people switched to a high-AGE diet show a rise in some inflammation markers. A caution: these trials are few, small and short, and every method of measuring AGEs has its blind spots.
Take an office worker who often orders fried chicken for delivery: the same chicken, boiled or steamed instead, would form far fewer AGEs.
In practice · Cooking with fewer AGEs
In the lab, four approaches clearly reduced new formation: moist heat such as boiling or steaming, shorter cooking times, lower temperatures, and marinating first in lemon juice or vinegar. A caution: the database measured mainly CML, using an antibody method, and covered only two of the many AGEs; the foods came from diets common in one large city in the northeastern US; and what fell was the content of the food, not any human outcome.
Frying and baking starchy foods also produce acrylamide. It too is a product of the Maillard reaction, formed from asparagine and sugars above about 120°C. It is not the kind of product formed when sugar attaches to a protein, so it is not an AGE, and the two should be kept apart.
Numbers · How much gets in, how much gets out
In people with normal kidney function, the urine over 48 hours carried out about 30% of what had been absorbed; in people with diabetes and kidney failure, this fell to under 5%. In the test tube, serum taken after the meal also showed activity that cross-links proteins.
A caution: it was a single meal with no randomization, the healthy and kidney-failure subgroups had only a handful of people each, AGEs were estimated with an antibody method, and the cross-linking toxicity was inferred from test-tube assays. Only a small part of the AGEs eaten reaches the blood, but people with weak kidneys clear them much more slowly.
Evidence · What the diet trials show
A 2014 trial randomly assigned 74 overweight women to a high- or low-AGE diet for 4 weeks, along with drinks containing fructose or glucose. After adjusting for changes in body measurements, the low-AGE group had lower urinary AGEs, fasting insulin and , an index of insulin resistance; adding fructose did not affect any outcome. The trial included only overweight women, lasted only 4 weeks, and looked at stand-in markers such as insulin rather than new cases of diabetes.
There are signals linking dietary AGEs to inflammation and insulin, but most studies fed heated foods, and whether the effects can be put down to AGEs still needs further confirmation.
Chapter 5
Taking apart anti-glycation pills
Ingredients these products commonly list include carnosine, alpha-lipoic acid, plant polyphenols such as anthocyanins, white kidney bean, bitter melon or mulberry leaf extract, vitamins C and E, and collagen. Even drugs designed specifically against glycation did not meet their primary end points once they reached large human trials.
Two things can actually move. One is lower blood sugar, which means fewer AGEs form inside the body: among people with type 1 diabetes, those whose blood sugar was kept lower over the long term had fewer glycation products in their skin collagen. The other is eating less food charred by dry heat, which means fewer AGEs come in with food; in a 4-week trial in overweight women, those on a low-AGE diet also had lower AGEs in their urine.
Take an office worker who comes across an anti-glycation drink in a livestream: for each ingredient on the bottle, ask one question, namely whether anyone has tested in people that it reduces AGEs. People with diagnosed diabetes or on glucose-lowering drugs should not use anti-glycation products in place of treatment, and should ask their doctor before adding any ingredient sold on lowering blood sugar.
Evidence · The ingredients one by one
For plant polyphenols such as anthocyanins, this story found only one set of human data: a 12-week study in women with diabetes, using a topical product that combined blueberry extract with a xyloside ingredient. Firmness, wrinkles and hydration improved, but the AGE content of the skin did not fall significantly. This was applied to the skin, not swallowed, and the review does not say whether the study had a control group.
For alpha-lipoic acid and oral collagen, none of the studies checked for this story has human data showing fewer AGEs. Vitamins C and E have no such data either, but high-dose supplements can distort readings, which matters if you are tracking your HbA1c.
So blocking glycation in a test tube does not mean that swallowing something will reduce the AGEs in your body.
Evidence · Large trials of anti-glycation drugs
In practice · Lower glucose peaks, less charring
White kidney bean, bitter melon and mulberry leaf extracts are sold on lowering blood sugar, and their only overlap with anti-glycation is after-meal blood sugar: to judge them, look at whether they lower after-meal blood sugar in people, not at anti-glycation marketing.
So what has human data is this: among people with type 1 diabetes, keeping blood sugar lower over the long term left less glycation in skin collagen; on the food side, lower heat and moist heat reduce the AGEs formed in the pan. The ingredients in a bottle have no data like this yet.
References (16)
- Gkogkolou, P., & Böhm, M. (2012). Advanced glycation end products: Key players in skin aging? Dermato-Endocrinology, 4(3), 259–270. https://doi.org/10.4161/derm.22028 10.4161/derm.22028
- Singh, R., Barden, A., Mori, T., & Beilin, L. (2001). Advanced glycation end-products: A review. Diabetologia, 44(2), 129–146. 10.1007/s001250051591
- ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., et al., on behalf of the American Diabetes Association. (2024). 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2024. Diabetes Care, 47(Suppl. 1), S20-S42. 10.2337/dc24-S002
- Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A., & Sakharkar, M. K. (2016). Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker Insights, 11, 95–104. 10.4137/BMI.S38440
- Tahara, Y., & Shima, K. (1995). Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care, 18(4), 440–447. 10.2337/diacare.18.4.440
- Monnier, V. M., Bautista, O., Kenny, D., Sell, D. R., Fogarty, J., Dahms, W., Cleary, P. A., Lachin, J., & Genuth, S. (1999). Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: Relevance of glycated collagen products versus HbA1c as markers of diabetic complications. Diabetes, 48(4), 870–880. https://doi.org/10.2337/diabetes.48.4.870 10.2337/diabetes.48.4.870
- Verzijl, N., DeGroot, J., Thorpe, S. R., Bank, R. A., Shaw, J. N., Lyons, T. J., Bijlsma, J. W. J., Lafeber, F. P. J. G., Baynes, J. W., & TeKoppele, J. M. (2000). Effect of collagen turnover on the accumulation of advanced glycation end products. Journal of Biological Chemistry, 275(50), 39027–39031. 10.1074/jbc.M006700200
- Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2011). Receptor for AGE (RAGE): Signaling mechanisms in the pathogenesis of diabetes and its complications. Annals of the New York Academy of Sciences, 1243, 88–102. https://doi.org/10.1111/j.1749-6632.2011.06320.x 10.1111/j.1749-6632.2011.06320.x
- Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G. E., & Vlassara, H. (2010). Advanced glycation end products in foods and a practical guide to their reduction in the diet. Journal of the American Dietetic Association, 110(6), 911–916.e12. 10.1016/j.jada.2010.03.018
- Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013). Advanced glycation endproducts in food and their effects on health. Food and Chemical Toxicology, 60, 10–37. 10.1016/j.fct.2013.06.052
- Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997). Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy. Proceedings of the National Academy of Sciences of the United States of America, 94(12), 6474–6479. https://doi.org/10.1073/pnas.94.12.6474 10.1073/pnas.94.12.6474
- Clarke, R. E., Dordevic, A. L., Tan, S. M., Ryan, L., & Coughlan, M. T. (2016). Dietary advanced glycation end products and risk factors for chronic disease: A systematic review of randomised controlled trials. Nutrients, 8(3), 125. 10.3390/nu8030125
- Ghodsi, R., & Kheirouri, S. (2018). Carnosine and advanced glycation end products: A systematic review. Amino Acids, 50(9), 1177–1186. 10.1007/s00726-018-2592-9
- Bolton, W. K., et al. (2004). Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. American Journal of Nephrology, 24(1), 32-40. 10.1159/000075627
- Lewis, E. J., et al. (2012). Pyridorin in type 2 diabetic nephropathy. Journal of the American Society of Nephrology, 23(1), 131-136. 10.1681/ASN.2011030272
- Mark, A. B., Poulsen, M. W., Andersen, S., Andersen, J. M., Bak, M. J., Ritz, C., Holst, J. J., Nielsen, J., de Courten, B., Dragsted, L. O., & Bügel, S. G. (2014). Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women. Diabetes Care, 37(1), 88–95. 10.2337/dc13-0842
Written from the sources listed above. Checked sentence by sentence against them in . No physician reviews this site: it explains how the body works, and it is not medical advice. How we make content
Spotted an error, or something unclear? Email us. We read every message, check it against the sources, and fix what's wrong.